Christopher Cano
Officer at TFF Pharmaceuticals, Inc. (TFFP)
Christopher Cano has filed 1 insider report with the SEC since September 2021, as officer at TFF Pharmaceuticals, Inc. (TFFP). The latest filing, on September 24, 2021, reports grant or award at TFF Pharmaceuticals, Inc. (TFFP).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Christopher Cano is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | Sep 24, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Questions about Christopher Cano
- What is Christopher Cano's role at TFF Pharmaceuticals, Inc.?
- Christopher Cano reports to the SEC as officer at TFF Pharmaceuticals, Inc. (TFFP), according to the latest filing on September 24, 2021.
- Has Christopher Cano bought or sold stock recently?
- No open-market purchases or sales by Christopher Cano are on file. The filings report grant or award.
- How do I get alerts when Christopher Cano files?
- Follow Christopher Cano on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher Cano (SEC CIK 0001826407). Totals count each trade once, skipping amendments whose original is on file, from Sep 24, 2021 on. View on SEC EDGAR